Related Experiment Video
Updated: May 19, 2026
08:32
Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Immune microenvironment in tumor progression: characteristics and challenges for therapy
Valerie Chew1, Han Chong Toh, Jean-Pierre Abastado
1Agency for Science, Technology and Research (A∗STAR), Biopolis, Singapore Immunology Network (SIgN), Singapore 138648.
Journal of Oncology
|August 29, 2012
Summary
The tumor microenvironment significantly impacts cancer. Understanding its immune interactions is key for developing new cancer therapies and improving patient prognosis.
Area of Science:
- Immunology
- Oncology
- Systems Biology
Background:
- The tumor microenvironment is crucial for cancer development, progression, and immune control.
- Its molecular and cellular composition dictates the balance between suppressive and cytotoxic immune responses.
- Tumor immunoediting and chronic inflammation can drive cancer progression.
Purpose of the Study:
- To summarize the multifaceted roles of the tumor microenvironment in cancer.
- To focus on immunological mediators influencing tumor progression and control.
- To highlight challenges and opportunities for future cancer therapies.
Main Methods:
- Review of current literature on tumor microenvironment and cancer immunology.
- Analysis of systems biology approaches to understand tumor-immune interactions.
- Synthesis of data on prognostic implications of antitumor responses.
Main Results:
- The immune microenvironment critically influences cancer outcomes.
- Antitumor immune responses within the tumor microenvironment correlate with better prognosis.
- Understanding these factors is vital for effective cancer management.
Conclusions:
- The tumor microenvironment is a key determinant in cancer progression and control.
- Manipulating the tumor microenvironment shows promise for novel cancer treatments.
- Further research into microenvironmental factors is essential for advancing cancer therapy.
Related Concept Videos
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...